NCT03298087 2025-08-01
Systemic and Tumor-Directed Therapy for Oligometastatic Prostate Cancer
VA Office of Research and Development
Phase 2 Completed
Clinical Trials
17 trialsNCT04390880 2025-05-16
PROSPYL
VA Greater Los Angeles Healthcare System
Phase 2 Completed
NCT01759771 2024-03-18
VD3PCa
VA Office of Research and Development
Phase 2 Completed
NCT00524277 2020-03-30
Vaccine Therapy in Treating Patients With Breast Cancer
San Antonio Military Medical Center
Phase 2 Completed
NCT01754909 2019-10-08
Mitigation of Radiation Pneumonitis and Fibrosis
VA Office of Research and Development
Phase 2 Completed
NCT00105599 2015-04-07
Effectiveness of the FairCare System for Patients With Advanced Illness
VA Office of Research and Development
Phase 2 Completed
NCT00004437 2015-03-25
Phase II Study of the Multichannel Auditory Brain Stem Implant for Deafness Following Surgery for Neurofibromatosis 2
FDA Office of Orphan Products Development
Phase 2 Completed
NCT00004688 2015-03-25
Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms
FDA Office of Orphan Products Development
Phase 2 Completed
NCT00056992 2015-03-25
Testing of ADI-PEG in Hepatocellular Carcinoma
FDA Office of Orphan Products Development
Phase 2 Completed
NCT00086203 2015-03-25
Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL)
FDA Office of Orphan Products Development
Phase 2 Completed
NCT00098033 2015-03-25
Investigation of Clofarabine in Acute Leukemias
FDA Office of Orphan Products Development
Phase 2 Completed
NCT00099593 2015-03-25
Immunization Against Tumor Cells in Sezary Syndrome
FDA Office of Orphan Products Development
Phase 2 Completed
NCT01032928 2015-01-01
RSPT
VA Office of Research and Development
Phase 2 Completed
NCT00100477 2013-09-25
Use of Topotecan in Patients With Refractory Acute Leukemia
VA Office of Research and Development
Phase 2 Completed
NCT00018538 2009-01-21
Calcifidol Therapy in Men With Cancer
VA Office of Research and Development
Phase 2 Completed
NCT00018551 2009-01-21
Chemoprevention With Folic Acid
VA Office of Research and Development
Phase 2 Completed
NCT00108290 2008-04-04
Chemotherapy, Hormone Therapy, and Surgery to Remove the Prostate Gland in Patients With High Risk Prostate Cancer
VA Office of Research and Development
Phase 2 Completed